Page last updated: 2024-11-08

biguanides and Psychotic Disorders

biguanides has been researched along with Psychotic Disorders in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kar, SK1
Shahi, MK1
Roy, P1
Hayes, JF1
Lundin, A1
Wicks, S1
Lewis, G1
Wong, ICK1
Osborn, DPJ1
Dalman, C1

Other Studies

2 other studies available for biguanides and Psychotic Disorders

ArticleYear
Understanding the anxiety phenomenology in psychotic prodrome: A case report.
    Asian journal of psychiatry, 2017, Volume: 28

    Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Biguanides; Clonazepam; Drug Therapy, Combinatio

2017
Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness.
    JAMA psychiatry, 2019, 04-01, Volume: 76, Issue:4

    Topics: Biguanides; Bipolar Disorder; Calcium Channel Blockers; Female; Hospitalization; Humans; Hydroxymeth

2019